Can-Fite Biopharma Ltd ADR Company Profile
NYSE: CANFHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 12:07 PM ET
Can-Fite Biopharma at a glance
Can-Fite Biopharma Ltd ADR (NYSE: CANF) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Ramat Gan, Israel. Can-Fite Biopharma is led by Mr. Motti Farbstein and employs about 5 people. At a market capitalization of $6.1 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001536196, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Can-Fite Biopharma do?
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis. It develops Namodenoson that is in Phase III clinical trial for the treatment of liver cancer; and Phase IIa for the treatment of pancreatic cancer; as well as in Phase IIb trial for the treatment of metabolic associated steatohepatitis; and CF602, which is in pre-clinical trial for the treatment of erectile dysfunction. In addition, It offers cannabinoids for treatment of conditions associated with elevated expression of the A3 adenosine receptors. Further, the company develops commercial predictive biomarker blood test kit for A3AR. It has license and collaboration agreement with CMS Medical to develop, manufacture, and commercialize Piclidenoson and Namodenoson. The company was formerly known as Can-Fite Technologies Ltd. and changed its name to Can-Fite BioPharma Ltd. in January 2001. The company was incorporated in 1994 and is headquartered in Ramat Gan, Israel.
Business description based on the company's public filings.
Company information
- Legal name
- Can-Fite Biopharma Ltd ADR
- Ticker
- NYSE: CANF
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Motti Farbstein
- Employees
- 5
- Headquarters
- 26 Ben Gurion Street, Ramat Gan, Israel
- Phone
- 972 3 924 1114
- Website
- canfite.com
- Market cap
- $6.06M
- SEC CIK
- 0001536196
Companies similar to Can-Fite Biopharma
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GELSGelteq Limited | 0.5456 | -0.58% | $5.84M | vs CANF |
| IMNNImunon Inc. | 1.04 | -2.80% | $5.84M | vs CANF |
| SCNXScienture Holdings Inc. | 3.84 | -0.52% | $6.31M | vs CANF |
| XCURExicure Inc. | 0.967 | -4.26% | $6.33M | vs CANF |
| KALAKALA BIO Inc. | 0.2982 | +0.54% | $5.77M | vs CANF |
| ENVBEnveric Biosciences Inc. | 1.45 | -4.61% | $6.49M | vs CANF |
| ALZNAlzamend Neuro Inc. | 1.36 | +1.49% | $6.56M | vs CANF |
| BGMSBio Green Med Solution Inc. | 0.8215 | +0.06% | $5.44M | vs CANF |